1. Home
  2. HTCR vs LABT Comparison

HTCR vs LABT Comparison

Compare HTCR & LABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

N/A

Current Price

$1.77

Market Cap

2.7M

Sector

Technology

ML Signal

N/A

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$0.79

Market Cap

2.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HTCR
LABT
Founded
2009
2006
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.2M
IPO Year
2022
2026

Fundamental Metrics

Financial Performance
Metric
HTCR
LABT
Price
$1.77
$0.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.1K
★ 563.0K
Earning Date
11-17-2026
11-18-2026
Dividend Yield
★ 145.25%
N/A
EPS Growth
★ 414.29
N/A
EPS
★ N/A
N/A
Revenue
★ $30,407,229.00
N/A
Revenue This Year
$118.88
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 39.19
N/A
52 Week Low
$0.15
$0.76
52 Week High
$3.97
$6.85

Technical Indicators

Market Signals
Indicator
HTCR
LABT
Relative Strength Index (RSI) 29.99 25.81
Support Level N/A N/A
Resistance Level $2.16 $2.13
Average True Range (ATR) 0.12 0.18
MACD -0.02 -0.05
Stochastic Oscillator 19.61 1.53

Price Performance

Historical Comparison
HTCR
LABT

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

Share on Social Networks: